PDFs by language
Our 24/7 cancer helpline provides support for people dealing with cancer. We can connect you with trained cancer information specialists who will answer questions about a cancer diagnosis and provide guidance and a compassionate ear.
Chat live online
Select the Live Chat button at the bottom of the page
At our National Cancer Information Center trained Cancer Information Specialists can answer questions 24 hours a day, every day of the year to empower you with accurate, up-to-date information to help you make educated health decisions. We connect patients, caregivers, and family members with valuable services and resources.
Or ask us how you can get involved and support the fight against cancer. Some of the topics we can assist with include:
For medical questions, we encourage you to review our information with your doctor.
Laser therapy is sometimes used to treat eye melanoma, especially when surgery or radiation are not possible.
This is the most common type of laser treatment for eye melanoma. It uses infrared light to heat and kill the tumor.
TTT alone is mainly used to treat very small eye melanomas because of side effects like bleeding, retinal detachment and blockage of blood vessels in the eye, as well as a high risk of recurrence (cancer coming back). More recently, TTT may be used as an adjuvant (additional) treatment after brachytherapy (plaque radiotherapy) to lower the risk of recurrence.
This treatment uses highly focused, high-energy light beams to burn tissue. It is rarely used now to treat eye melanoma because of side effects and a high risk of recurrence, but it can be effective for very small melanomas.
As with radiation therapy, the main concern with laser therapy is damage to parts of the eye that could result in loss of vision. The risk depends on the size and location of the tumor.
The American Cancer Society medical and editorial content team
Our team is made up of doctors and oncology certified nurses with deep knowledge of cancer care as well as journalists, editors, and translators with extensive experience in medical writing.
Finger PT. Chapter 116: Intraocular melanoma. In: DeVita VT, Lawrence TS, Rosenberg SA, eds. DeVita, Hellman, and Rosenberg’s Cancer: Principles and Practice of Oncology. 10th ed. Philadelphia, Pa: Lippincott Williams & Wilkins; 2015.
Grisanti S, Tura A. Uveal Melanoma. In Scott JF, Gerstenblith MR, eds. Noncutaneous Melanoma [Internet]. Brisbane (AU): Codon Publications; 2018 Mar. Available from: https://www.ncbi.nlm.nih.gov/books/NBK506988/ doi: 10.15586/codon.noncutaneousmelanoma.2018.
Karcioglu ZA, Haik BG. Chapter 67: Eye, orbit, and adnexal structures. In: Niederhuber JE, Armitage JO, Dorshow JH, Kastan MB, Tepper JE, eds. Abeloff’s Clinical Oncology. 5th ed. Philadelphia, Pa. Elsevier: 2014.
National Cancer Institute. Physician Data Query (PDQ). Intraocular (Uveal) Melanoma Treatment. 2018. Accessed at https://www.cancer.gov/types/eye/hp/intraocular-melanoma-treatment-pdq#link/_101_toc. Accessed August 24, 2018.
National Comprehensive Cancer Network. NCCN Clinical Practice Guidelines in Oncology: Uveal Melanoma. V.1.2018. Accessed at https://www.nccn.org/professionals/physician_gls/pdf/uveal.pdf on August 15, 2018.
Last Revised: November 30, 2018
American Cancer Society medical information is copyrighted material. For reprint requests, please see our Content Usage Policy.